Dr. Vincent J. Picozzi is Director for the Pancreaticobiliary Program at Virginia Mason Medical Center. A summa cum laude, Phi Beta Kappa graduate from Yale University, Vincent obtained his MD degree from Stanford University, did his internship and residency at Harvard University (Brigham and Women’s Hospital) and fellowships in hematology and oncology again at Stanford. He also holds a Master’s degree in Medical Management, Delta Omega, from Tulane University. Vincent was an instructor in hematology and oncology at Stanford for two years before joining Virginia Mason, where he has been for the past 36 years.
Vincent has one of the largest pancreaticobiliary oncology practices in the United States. He has received numerous accolades as a clinician, including designation as one of Seattle’s Best Doctors and one of America’s Top Cancer Doctors for the last fifteen consecutive years (2008-2022). He also directs an active, comprehensive clinical and translational research program in pancreaticobiliary cancer at Virginia Mason and has published nearly 200 papers and abstracts.
Vincent has educational committees for the GI Oncology Symposium and ASCO for non-colorectal cancers and served as Educational Chair for both in 2016. He has been a featured speaker at virtually every major clinical oncologic meeting in the United States, including ASCO (the American Society of Clinical Oncology), ASH (the American Society of Hematology), ASTRO (the American Society of Therapeutic Radiation Oncology), Digestive Diseases Week, AHPBA (The American Hepatopancreaticobiliary Association), ACOS (the American College of Surgeons), the Best of ASCO, the GI Oncology Symposium and the World Pancreas Symposium.
Vincent also has held a number of leadership positions with national and regional organizations, including ASCO, ASH, the American College of Surgeons Oncology Group (ACOSOG), the Pancreatic Cancer Action Network where he is a past chairman and current board member for the Scientific and Medical Advisory Board, the Pancreas Cancer Research Team (PCRT-Executive Committee) and the Providence Hospice of Seattle (Executive Board). He also has proudly served on the Executive Board of the Washington State Medical Oncology Society since its inception 30 years ago, twice serving as president. Recently, Vincent is the co-principal investigator and Clinical Trials Consortium chairman of the new Precision Promise Clinical Research Consortium sponsored by the Pancreatic Cancer Action Network.
